Yarrow Bioscience (YARW) Long-Term Investments (2016 - 2019)

Yarrow Bioscience (YARW) has 4 years of Long-Term Investments data on file, last reported at $2.0 million in Q3 2019.

• Quarterly Long-Term Investments changed N/A year-over-year to $2.0 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $2.0 million (changed N/A YoY) and the FY2017 annual result came in at $3.0 million, down 71.42% from the prior year.
• Long-Term Investments eased to $2.0 million in Q3 2019, from $10.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $20.7 million in Q1 2018 to a low of $2.0 million in Q3 2019.
• A 4-year average of $9.3 million and a median of $10.4 million in 2016 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 71.42% in 2017, down 71.42% in 2017.
• Tracing YARW's Long-Term Investments over 4 years: stood at $10.4 million in 2016, then tumbled by 71.42% to $3.0 million in 2017, then jumped by 250.07% to $10.4 million in 2018, then sank by 80.78% to $2.0 million in 2019.
• The last three Long-Term Investments figures came in at $2.0 million (Q3 2019), $10.4 million (Q2 2018), and $20.7 million (Q1 2018), per Business Quant data.